Merck KGaA Develops Asia Hub In Taiwan, Looking To Expand
This article was originally published in PharmAsia News
SHANGHAI - Merck KGaA and Taiwan's Development Center for Biotechnology announced Oct. 29 the opening of Merck's Asian Technology and Training Center in Taiwan
You may also be interested in...
BOSTON - Taiwan's Bureau of Pharmaceutical Affairs and Center for Drug Evaluation brought a large delegation to promote the country's clinical trial environment at the Drug Information Association's 44th annual meeting held this year in Boston. BPA Deputy-Director General Li-Ling Liu and CDE Executive Director Herng-Der Chern, spoke with PharmAsia News on the sidelines of the conference about the country's efforts to make Taiwan an attractive location for clinical development
Taiwan's Cabinet gave its approval of intellectual property rights regulations adopted by the World Trade Organization. The WTO amendment remains to be ratified by the end of next year by Taiwan's legislature. The Trade-Related Aspects of Intellectual Property Rights allows countries without makers of generics drugs to import generics under a well-defined compulsory licensing procedure. (Click here for more
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).